Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia
- 7 February 2006
- Vol. 38 (6) , 888-892
- https://doi.org/10.1016/j.bone.2005.11.018
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Abnormalities in Bone Mineral Density and Bone Histology in ThalassemiaJournal of Bone and Mineral Research, 2003
- Vitamin D in preventive medicine: are we ignoring the evidence?British Journal of Nutrition, 2003
- Hypoparathyroidism in Transfusion-Dependent Patients With β-ThalassemiaJournal of Pediatric Hematology/Oncology, 2002
- Vitamin D metabolites (25‐hydroxyvitamin D, 24,25‐dihydroxyvitamin D and 1,25‐dihydroxyvitamin D) and osteocalcin in β‐thalassaemiaActa Paediatrica, 1997
- The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approachesClinical Endocrinology, 1995
- Bone density, mineral content, and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusions, and treatment with desferrioxamineCalcified Tissue International, 1992
- Bone disease in children with homozygous β-thalassemiaBone and Mineral, 1990
- AGE, VITAMIN D, AND SOLAR ULTRAVIOLETThe Lancet, 1989
- Serum 1,25 dihydroxyvitamin D and osteocalcin concentrations in thalassaemia major.Archives of Disease in Childhood, 1987
- Seasonal Changes in Human Plasma Levels of 25-Hydroxyvitamin DNature, 1974